Central effects of DN1417, a novel TRH analog, on plasma glucose and catecholamines in conscious rats
- 1 April 1985
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 36 (13) , 1287-1294
- https://doi.org/10.1016/0024-3205(85)90274-7
Abstract
No abstract availableFunding Information
- Ministry of Education
- Ministry of Health, Labour and Welfare
This publication has 15 references indexed in Scilit:
- Inhibition by Gastrin-Releasing Peptide of Growth Hormone (GH) Secretion Induced by Human Pancreatic GH-Releasing Factor in Rats*Endocrinology, 1984
- Glucagon-induced somatostatin release from perifused rat hypothalamus: Calcium dependency and effect of cysteamine treatmentNeuroscience Letters, 1983
- Thyrotropin-Releasing HormoneNew England Journal of Medicine, 1982
- SOMATOSTATIN IN RAT TISSUES IS DEPLETED BY CYSTEAM.INE ADMINISTRATION1Endocrinology, 1981
- Thyrotropin releasing factor: A putative CNS regulator of the automatic nervous systemLife Sciences, 1981
- γ-butyrolactone-γ-carbonyl-histidyl-prolinamide citrate (DN-1417) : A novel TRH analog with potent effects on the central nervous systemLife Sciences, 1981
- β-Endorphin-induced hyperglycemia is mediated by increased central sympathetic outflow to adrenal medullaBrain Research, 1981
- Somatostatin Analog: Plasma Catecholamine Suppression Mediated by the Central Nervous System*Endocrinology, 1980
- Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: Comparison with a radioenzymatic methodLife Sciences, 1979
- Somatostatin: Central Nervous System Actions on GlucoregulationEndocrinology, 1979